Forte Biosciences, Inc. (FBRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 401.33M |
| Enterprise Value | 324.38M |
| P/E Ratio | -16.76 |
| PEG Ratio | -0.43 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9.96 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -17.69 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.43 |
| Return On Equity | -0.95 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -64,000 |
| EBITDA | -68.27M |
| Net Income | -69.38M |
| Diluted EPS | -4.71 |
| Total Cash | 198.46M |
| Total Cash/Share | 8.34 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.01 |
| Book Value Per Share | 7.73 |
| 52-Week Change | 572.97 |
| 52-Week High | 77.2 |
| 52-Week Low | 10.11 |
| Moving Average 50 Days | 49.18 |
| Moving Average 200 Days | 31.22 |
| Average Volume | 1.31M |
| Shares Outstanding | 20.49M |
| % Held by Institutions | 9.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 28, 2024 |